Release

Commonwealth Biotechnologies, Inc. and UAlbany's Center for Functional Genomics Sign Strategic Alliance Agreement
Agreement extends reach of both in the life sciences service sector

Contact: Catherine Herman (518) 437-4980

ALBANY, N.Y. (February 22, 2006) -- Commonwealth Biotechnologies, Inc. (NASDAQ Capital Market: CBTE) and The University at Albany's Center for Functional Genomics (CFG) announced today that they have signed a Strategic Alliance Agreement to co-market their respective services to the life sciences industry. The Agreement provides for ready access to the combined capabilities of the two organizations and will enable better overall technology solutions to be developed for their clients in the life sciences industry.

"This Agreement affords CBI clients access to an extended set of very high end services that can be combined with our existing technology base to provide the most comprehensive array of cutting edge capabilities in the industry," said Richard J. Freer, Chairman & COO of CBI. "On the other hand, CFG will now be able to offer support for their clients who are seeking to meet the FDA requirements for submission of data in support of new drug applications. This is a powerful combination for both of our client bases."

"The CFG was established to support academic research and foster the growth of the biotechnology industry," said CFG Director Paulette McCormick. "We accomplish this by giving bioscience researchers access to a broad array of state-of-the-art instrumentation which is otherwise too costly or inefficient for individual researchers or companies to maintain on their own. Our new alliance with CBI will allow our clients to leverage the expertise of CBI's product development teams and will help our clients convert their basic research into medically and scientifically valuable products."

Commonwealth Biotechnologies, Inc. is a solutions provider to the global biotechnology industry, academic institutions, government agencies, and pharmaceutical companies. It offers broad ranging expertise and a complete array of the most current analytical and synthetic chemistries and biophysical analysis technologies. CBI offers comprehensive genetic identity testing, including paternity, forensic, and CODIS analyses. CBI is accredited by the American Association of Blood Banks, CLIA, and the National Forensic Science Technology Council, and operates fully accredited BSL-3 laboratory. Founded in 1992, CBI is located in Gateway Centre, Chesterfield County at 601 Biotech Drive, 23235 (1-800-735-9224). For more information, visit CBI on the web at www.cbi-biotech.com and visit FIL at www.fairfaxidlab.com.

CFG provides basic laboratory services to hundreds of bioscience researchers at companies, universities and government agencies around the world. Core competencies include expertise in molecular genetics, mouse transgenics, microarray, proteomics, tissue culture, flow cytometry and laser- and UV-capture microdissection services. CFG partners with organizations and researchers on projects ranging from single sample analyses to long-term work as collaborators or subcontractors on NIH grants. The University at Albany's Center for Functional Genomics is an operating unit of the Research Foundation of the State University of New York (SUNY). For more information, visit www.cfgbiotech.com.